medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2005; 4 (4)


Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center

Chiquete E, Sánchez LV, Becerral G, Quintero Á, Maldonado M, Panduro A

Idioma: Ingles.
Referencias bibliográficas: 15
Paginas: 275-278
Archivo PDF: 50.60 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-33.

  2. Rivera-López MR, Zavala-Méndez C, Arenas-Esqueda A. Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors [in Spanish]. Gac Med Mex 2004; 140: 657-660.

  3. SSA. Mexican Official Norm on the use of human blood and its components with therapeutic objectives (NOM-003-SSA2-1993); Mexico, 1993. Available at http://www.salud.gob.mx/. Accessed July 25 2005.

  4. Méndez-Sánchez N, Villa AR, Chávez-Tapia NC, Ponciano-Rodríguez G, Almeda-Valdés P, González D, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-55.

  5. Sookoian S, Castaño G. Evaluation of a third generation anti-HCV assay in predicting viremia in patients with positive HCV antibodies. Ann Hepatol 2002; 4: 179-182.

  6. Dal Molin G, Tiribelli C, Campello C. A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection. Ann Hepatol 2003; 2: 76-83.

  7. Chiquete E, Sánchez LV, Maldonado M, Quezada D, Panduro A. Prediction of the hepatitis C viremia using immunoassay data and clinical expertise. Ann Hepatol 2005; 4: 107-114.

  8. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004; 50: 159-162.

  9. Rivas-Estilla AM, Sánchez LV, Matsui O, Campollo O, Armendariz-Borunda J, Segura-Ortega JE, Panduro A. Identification of hepatitis C virus (HCV) genotypes in infected patients from the west of Mexico. Hepatology Research 1998; 12: 121-130.

  10. Sánchez LV, Maldonado M, Bastidas-Ramírez BE, Norder H, Panduro A. Genotypes and S-gene variability of Mexican hepatitis B virus strains. J Med Virol 2002; 68: 22-34.

  11. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-567.

  12. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351: 760-768.

  13. Koerner K, Cardoso M, Dengler T, Kerowgan M, Kubanek B. Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang 1998; 74: 213-216.

  14. Flanagan P, Snape T. Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing. Transfusion Med 1998; 8: 9-13.

  15. Romano L, Velati C, Baruffi L, Fomiatti L, Colucci G, Zanetti AR, et al. Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations. J Clin Microbiol 2005; 43: 2991-2993.




2020     |     www.medigraphic.com